Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation ProtocolLouise Sigfrid, J. T. Scott, Thomas M Drake et al.|The Lancet Regional Health - Europe|2021Cited by 322
Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi ArabiaYaseen M. Arabi, Ali H. Hajeer, Thomas Luke et al.|Emerging infectious diseases|2016Cited by 259
Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocolYaseen M. Arabi, Robert Fowler, Hanan H. Balkhy et al.|SpringerPlus|2015Cited by 206
What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocolLouise Sigfrid, J. T. Scott, Müge Çevik et al.|BMJ Open|2021Cited by 105
Open source clinical science for emerging infectionsJake Dunning, J. Kenneth Baillie, Laura Merson et al.|The Lancet Infectious Diseases|2013Cited by 98